Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 5 pseudogene 2 (CCT5P2)
- Target
- CCT5P2
- Molecular classification
- Other (pseudogene)
01
Overview
CCT5P2 (Chaperonin containing TCP1 subunit 5 pseudogene 2) is a human pseudogene located on chromosome 13 (13q31), annotated in genomic databases such as GeneCards, MARRVEL, BioGPS, and EMBL-EBI GWAS Catalog. Pseudogenes are segments of DNA that resemble protein-coding genes but do not encode functional proteins and generally lack regulatory or enzymatic activity. CCT5P2 is related by sequence similarity to the functional gene CCT5 (Chaperonin containing TCP1 subunit 5), which codes for a component of the chaperonin-containing TCP1 complex involved in ATP-dependent protein folding, but CCT5P2 itself does not produce any functional protein, and there is no scientific evidence for direct biological or disease roles.
- Other names
- CCT5-P1Chaperonin containing TCP1, subunit 5 (epsilon) pseudogene 2CCT5P2
02
Mechanism of action
None. No drugs target or act on CCT5P2
03
Biological functions
None established. As a pseudogene, CCT5P2 does not encode a functional protein or have defined biological roles
04
Disease associations
None. No demonstrated involvement in disease; pseudogenes may be referenced in genomic studies but do not have established disease mechanisms or roles
05
Safety considerations
None. There are no safety or therapeutic challenges associated, as CCT5P2 is not a target
06
Interacting drugs
None. There are no known drugs that interact with CCT5P2, due to its lack of protein product
07
Biomarkers
None. There are no established uses as biomarkers for patient selection or monitoring
Beyond the preview
Go deeper on Chaperonin containing TCP1 subunit 5 pseudogene 2 (CCT5P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 5 pseudogene 2 (CCT5P2).